EAM Investors’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.28M Sell
64,803
-1,020
-2% -$71.7K 0.47% 96
2026
Q1
$3.75M Buy
+65,823
New +$3.82M 0.43% 105
2020
Q3
Sell
-15,151
Closed -$1.7M 339
2020
Q2
$1.7M Buy
+15,151
New +$1.56M 0.38% 126
2014
Q3
Sell
-16,505
Closed -$1.35M 353
2014
Q2
$1.35M Buy
16,505
+989
+6% +$67K 0.26% 192
2014
Q1
$1.05M Sell
15,516
-803
-5% -$59.7K 0.19% 290
2013
Q4
$1.16M Buy
16,319
+1,337
+9% +$104K 0.21% 269
2013
Q3
$1.14M Sell
14,982
-1,319
-8% -$91.3K 0.23% 198
2013
Q2
$1.06M Buy
+16,301
New +$876K 0.23% 200

Other funds holding PRLB

EAM Investors's PRLB Position: Q2 2026 in Review

EAM Investors reduced its Protolabs (PRLB) stake by 1.5% in Q2 2026, selling an estimated $71.7K and leaving 64,803 shares worth $5.28M. The position accounts for 0.47% of the portfolio, ranked #96.

EAM Investors first reported a position in PRLB in Q2 2013 and has held it in 8 quarters since. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • EAM Investors held 64,803 shares of Protolabs worth $5.28M as of Q2 2026.
  • EAM Investors sold 1,020 Protolabs shares in Q2 2026, an estimated $71.7K.
  • Protolabs made up 0.47% of EAM Investors's portfolio in Q2 2026, its #96 holding.
  • EAM Investors first reported a position in Protolabs in Q2 2013 and has held it in 8 quarters since.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.